CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21 enrolled
Drug / intervention
Prostate Artery Embolizationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02930889
NCT02930889N/ACompleted
CompareCT.gov

Prostate Artery Embolization (PAE) for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

University of Minnesota·interventional·Posted Oct 12, 2016·Updated Dec 2, 2021

In Brief

A clinical study evaluating Prostate Artery Embolization for Benign Prostatic Hyperplasia. Completed, enrolled 21 participants across 1 site.

Detailed Summary

This is a investigator-initiated evaluation of the safety and efficacy of treating benign prostatic hyperplasia (BPH) by prostatic artery embolization.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBenign Prostatic Hyperplasia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedOct 12, 2016
Enrollment StartOct 1, 2016
Primary CompletionOct 31, 2020
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 9.7 years ago

Interventions

Prostate Artery Embolizationdevice

Prostate Artery Embolization